Author:
Vasilev Veselin,Boyadjiev Nikolay,Hrischev Petar,Gerginska Fanka,Delchev Slavi,Arabadzhiyska Desislava,Komrakova Marina,Boeker Kai O.,Schilling Arndt F.,Georgieva Katerina
Abstract
AbstractThe purpose of this study is to study the effects of ostarine alone and in combination with endurance training in sexually mature, male Wistar rats. The rats were divided into a treadmill-trained group and a sedentary group. Half of each group received either ostarine or vehicle for 8 weeks (n = 10 each, in total n = 40). We examined some functional, hormonal, and anthropometric parameters and the myogenic gene expression of myostatin, insulin-like growth factor-1 (IGF-1), and vascular endothelial growth factor-A (VEGF-A) in m. gastrocnemius. Ostarine decreased submaximal endurance and increased myogenic gene expression of myostatin but had no effect on maximal time to exhaustion and grip strength. Training increased submaximal endurance, maximal time to exhaustion, and grip strength. Our results indicate that both exercise and ostarine treatment had no significant effects on serum levels of luteinizing hormone, follicle-stimulating hormone, and testosterone, or on the myogenic gene expression of IGF-1 and VEGF-A. Neither ostarine nor the training had a significant effect on the testis, liver, and heart weights. In conclusion, ostarine had no effect on anthropometric and hormonal parameters but increased the myostatin gene expression in muscle. The SARM treatment decreased submaximal endurance without affecting maximal time to exhaustion, and training increased both metrics.
Publisher
Springer Science and Business Media LLC
Reference47 articles.
1. Arazi H, Babaei P, Moghimi M, Asadi A (2021) Acute effects of strength and endurance exercise on serum BDNF and IGF-1 levels in older men. BMC Geriatr 21(1):50. https://doi.org/10.1186/s12877-020-01937-6
2. Bhasin S (2015) Selective androgen receptor modulators as function promoting therapies. J Frailty Aging 4(3):121–122. https://doi.org/10.14283/jfa.2015.65
3. Boyadjiev NP, Georgieva KN, Massaldjieva RI, Gueorguiev SI (2000) Reversible hypogonadism and azoospermia as a result of anabolic-androgenic steroid use in a bodybuilder with personality disorder. A case report. J Sports Med Phys Fit. 40(3):271–4
4. Boyadjiev NP, Nikolova JG, Muletarov SM, Nikolov FP, Moshekov EK (2010) Changes in some anthropometric, hemodynamic, echocardiographic, and clinicochemical parameters in bodybuilders using anabolic-androgenic steroids. Int J Fit 6(2):27
5. Chen J, Hwang DJ, Bohl CE, Miller DD, Dalton JT (2005) A selective androgen receptor modulator for hormonal male contraception. J Pharmacol Exp Ther 312(2):546–553. https://doi.org/10.1124/jpet.104.075424